{
    "clinical_study": {
        "@rank": "67233", 
        "arm_group": [
            {
                "arm_group_label": "Patients with chronic heart failure", 
                "description": "other"
            }, 
            {
                "arm_group_label": "Healthy volontiers", 
                "description": "other"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to describe insulin resistance in a general chronic heart\n      failure population, in combination with muscle strength, body composition and cardiac\n      function.\n\n      It is assumed that insulin resistance is increased in CHF patient, and that this is related\n      to decreased muscle strength and decreased lean tissue mass."
        }, 
        "brief_title": "Description of Insulin Resistance in Patients With Chronic Heart Failure", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Chronic Heart Failure", 
        "condition_browse": {
            "mesh_term": [
                "Heart Failure", 
                "Insulin Resistance"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  diagnosis of chronic heart failure for at least 6 months,\n\n          -  clinically stable (not hospitalized) for more than 3 months prior to the onset of the\n             study,\n\n        Exclusion Criteria:\n\n          -  glucose lowering medical therapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "patients with chronic heart failure"
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02013739", 
            "org_study_id": "11.78/cardio11.13"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Hasselt", 
                    "country": "Belgium", 
                    "state": "Limburg", 
                    "zip": "3500"
                }, 
                "name": "Hasselt University"
            }
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_groups": "2", 
        "official_title": "Description of Insulin Resistance and Explanatory Variables in Patients With Chronic Heart Failure", 
        "overall_official": {
            "affiliation": "Hasselt University", 
            "last_name": "Bert Op 't Eijnde, prof. dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Belgium: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "glucose and insulin concentration measurements in blood during oral glucose tolerance test", 
            "measure": "Glucose tolerance", 
            "safety_issue": "No", 
            "time_frame": "day1"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02013739"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hasselt University", 
            "investigator_full_name": "Bert Op't Eijnde", 
            "investigator_title": "prof. dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "HbA1c, blood lipids, BNP", 
                "safety_issue": "No", 
                "time_frame": "day 1"
            }, 
            {
                "measure": "Muscle strength: maximal strength tested on a isokinetic dynamometer", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "Body composition: dual energy x-ray absorptiometry", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "cardiac function: echocardiography, retrospective from hospital files", 
                "safety_issue": "No", 
                "time_frame": "retrospective"
            }, 
            {
                "measure": "Health-related quality of life: MLHFQ and Eq5d", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }
        ], 
        "source": "Hasselt University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hasselt University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2011", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}